Antibody tests for identification of current and past infection with SARS‐CoV‐2
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Humoral responses and serological assays in SARS-CoV-2 infections
Y Galipeau, M Greig, G Liu, M Driedger… - Frontiers in …, 2020 - frontiersin.org
In December 2019, the novel betacoronavirus Severe Acute Respiratory Disease
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …
Coronavirus 2 (SARS-CoV-2) was first detected in Wuhan, China. SARS-CoV-2 has since …
Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients
Methods| Transplant recipients without prior polymerase chain reaction–confirmed COVID-
19 were recruited from across the US to participate in this prospective cohort through a …
19 were recruited from across the US to participate in this prospective cohort through a …
Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients
Methods| Transplant recipients across the US were recruited though social media to
participate in this prospective cohort, and those who underwent SARS-CoV-2 vaccination …
participate in this prospective cohort, and those who underwent SARS-CoV-2 vaccination …
Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 …
Importance After an infection by SARS-CoV-2, many patients present with persistent
physical symptoms that may impair their quality of life. Beliefs regarding the causes of these …
physical symptoms that may impair their quality of life. Beliefs regarding the causes of these …
[HTML][HTML] Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
RECOVERY Collaborative Group - Lancet (London, England), 2021 - ncbi.nlm.nih.gov
Background Many patients with COVID-19 have been treated with plasma containing anti-
SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent …
SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent …
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
Characterization of the T cell response in individuals who recover from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is critical to understanding its …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is critical to understanding its …
Anti-spike protein assays to determine SARS-CoV-2 antibody levels: a head-to-head comparison of five quantitative assays
T Perkmann, N Perkmann-Nagele, T Koller… - Microbiology …, 2021 - Am Soc Microbiol
Reliable quantification of the antibody response to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is highly relevant, eg, for identifying possible vaccine failure …
coronavirus 2 (SARS-CoV-2) is highly relevant, eg, for identifying possible vaccine failure …
SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients
DF Ruether, GM Schaub, PM Duengelhoef… - Clinical …, 2022 - Elsevier
Background & Aims Detailed information on the immune response after second vaccination
of cirrhotic patients and liver transplant (LT) recipients against severe acute respiratory …
of cirrhotic patients and liver transplant (LT) recipients against severe acute respiratory …
The BNT162b2 mRNA vaccine elicits robust humoral and cellular immune responses in people living with human immunodeficiency virus (HIV)
Previous studies have shown that certain vaccines induce suboptimal responses in people
living with human immunodeficiency virus (HIV, PLWH). However, responses to severe …
living with human immunodeficiency virus (HIV, PLWH). However, responses to severe …